Bespoke Extracts (BSPK) 10-QT 24 Mar 22 2021 Q1 Quarterly report for transitional period Financial data

Document And Entity Information

Document And Entity Information - shares	4 Months Ended
	Dec. 31, 2021	Mar. 24, 2022
Document Information Line Items
Entity Registrant Name	BESPOKE EXTRACTS, INC.
Document Type	10-QT
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		385,531,119
Amendment Flag	false
Entity Central Index Key	0001409197
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Document Quarterly Report	false
Document Transition Report	true
Document Period Start Date	Sep. 1, 2021
Entity File Number	000-52759
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	20-4743354
Entity Address, Address Line One	2590 Walnut St
Entity Address, City or Town	Denver
Entity Address, Country	CO
Entity Address, Postal Zip Code	80205
Entity Interactive Data Current	Yes
City Area Code	855
Local Phone Number	633-3738

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($)	Dec. 31, 2021	Aug. 31, 2021
Current assets
Cash	$ 148,227	$ 11,177
Accounts receivable, net	3,636	5,262
Prepaid expense	6,439	24,329
Inventory, net	46,825	48,259
Total current assets	205,127	89,027
Furniture and equipment	2,745	2,745
Right of Use Asset	339,780
Deposits	12,000
Domain names, net of amortization of $0 and $14,116, respectively		32,748
Total assets	559,652	124,520
Current liabilities
Accounts payable and accrued liabilities	82,729	42,228
Inventory earn-out	75,000
Note payable - related party	2,500	534
Operating lease liability	59,777
Convertible notes		500,000
Total current liabilities	220,006	542,762
Long-Term Operating Lease Liability	280,369
Total liabilities	500,375	542,762
Commitments and contingencies (Note 9)
Stockholders' Equity / (Deficit)
Preferred stock, par value $0.001, 50,000,000 shares authorized, 1 share issued and outstanding as of December 31, 2021 and August 31,2021, respectively
Series C Preferred Stock, $0.001 par value, 1 share designated; 1 share issued and outstanding as of December 31, 2021 and August 31, 2021, respectively, stated value $24,000.
Common stock, $0.001 par value: 3,000,000,000 authorized; 366,679,924 and 246,888,426 shares issued and 299,179,924 and 248,888,426 shares outstanding as of December 31, 2021 and August 31, 2021, respectively	299,180	246,889
Additional paid-in capital	19,527,669	19,077,135
Accumulated deficit	(19,767,572)	(19,742,266)
Total stockholders' equity / (deficit)	59,277	(418,242)
Total liabilities and stockholders' equity / (deficit)	$ 559,652	$ 124,520

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2021	Aug. 31, 2021
Net of amortization (in Dollars)	$ 0	$ 14,116
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	1	1
Preferred stock, shares outstanding	1	1
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	366,679,924	246,888,426
Common stock, shares outstanding	299,179,924	248,888,426
Series C Convertible Preferred Stock
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares issued	1	1
Preferred stock, shares outstanding	1	1
Preferred stock, designated shares	1	1
Preferred stock, share stated value (in Dollars)	$ 24,000	$ 24,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	4 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Sales	$ 4,646	$ 8,355
Cost of products sold	2,070	2,985
Gross Profit	2,576	5,370
Operating expenses:
Selling, general and administrative expenses	215,732	234,395
Professional fees	74,067	46,425
Consulting	33,000	63,000
Amortization expense of domain name		811
Total operating expenses	322,799	344,631
Loss from operations	(320,223)	(339,261)
Other income
Gain on settlement of debt	292,252
Gain on settlement of accrued expenses	2,665
Total other income	294,917
Loss before income tax	(25,306)	(339,261)
Provision for income tax
Net Loss	$ (25,306)	$ (339,261)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic and Diluted (in Shares)	250,839,246	207,380,299
NET LOSS PER COMMON SHARE OUTSTANDING
Basic and Diluted (in Dollars per share)	$ 0	$ 0

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	4 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net Loss	$ (25,306)	$ (339,261)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization expense of domain names		811
Bad debt allowance	1,039
Amortization of Right of Use Asset	5,216
Gain on settlement of debt	(292,252)
Gain on settlement of accrued expenses	(2,665)
Common stock issued for services	7,987
Stock based compensation and stock option expense	143,304
Changes in operating assets and liabilities:
Accounts receivable	587	414
Prepaid expense	17,890	(13,600)
Inventory	1,434	(41,723)
Deposits	(12,000)
Operating lease liability	(4,850)
Accounts payable and accrued liabilities	54,166	21,012
Net Cash used in operating activities	(105,450)	(372,347)
Cash flows from investing activities
Purchase of Url		(2,250)
Purchase of equipment		(2,745)
Net cash used in investing activities		(4,995)
Cash flow from financing activities
Proceeds from note payable - related party	62,500	130,534
Repayments from note payable - related party	(60,000)
Proceeds from the units offering, net of costs and sale of common stock	240,000	200,000
Net cash provided by financing activities	242,500	330,534
Net increase / (decrease) in cash	137,050	(46,808)
Cash at beginning of period	11,177	126,603
Cash at end of period	148,227	79,795
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities:
Stock issued for conversion of debt - related party		150,000
Capital contribution of accrued salary - related party	11,000
Forgiveness of note payable - related party	534
Right of use asset obtained in exchange for operating lease liability	344,996
Common stock issued for the conversion of debt	$ 100,000

Condensed Statement of Stockhol

Condensed Statement of Stockholders Equity / (Deficit) (Unaudited) - USD ($)	Series CPreferred Shares	Common Shares	Additional Paid-in Capital	Common Stock Payable	Accumulated Deficit	Total
Balance at Aug. 31, 2020		$ 194,389	$ 17,992,635	$ 76,000	$ (18,776,689)	$ (513,665)
Balance (in Shares) at Aug. 31, 2020	1	194,388,426
Common stock for conversion of note payable - related party		$ 15,000	135,000			150,000
Common stock for conversion of note payable - related party (in Shares)		15,000,000
Sale of common stock		$ 20,000	180,000			200,000
Sale of common stock (in Shares)		20,000,000
Forgiveness of note payable - related party
Net loss					(339,261)	(339,261)
Balance at Dec. 31, 2020		$ 229,389	18,307,635	$ 76,000	(19,115,950)	(502,926)
Balance (in Shares) at Dec. 31, 2020	1	229,388,426
Balance at Aug. 31, 2021		$ 246,889	19,077,135		(19,742,266)	(418,242)
Balance (in Shares) at Aug. 31, 2021	1	246,888,426
Capital contribution of accrued salary - related party			11,000			11,000
Forgiveness of note payable - related party			534			534
Common stock for the conversion of notes payable		$ 2,000	98,000			100,000
Common stock for the conversion of notes payable (in Shares)		2,000,000
Stock based compensation and stock option expense			143,304			143,304
Common stock issued for services		$ 291	7,696			7,987
Common stock issued for services (in Shares)		291,498
Unit Offering, net of expenses of $10,000		$ 50,000	190,000			240,000
Unit Offering, net of expenses of $10,000 (in Shares)		50,000,000
Net loss					(25,306)	(25,306)
Balance at Dec. 31, 2021		$ 299,180	$ 19,527,669		$ (19,767,572)	$ 59,277
Balance (in Shares) at Dec. 31, 2021	1	299,179,924

Condensed Statement of Stockh_2

Condensed Statement of Stockholders Equity / (Deficit) (Unaudited) (Parentheticals)	4 Months Ended
	Dec. 31, 2021USD ($)
Statement of Stockholders' Equity [Abstract]
Net of expenses	$ 10,000

Nature of Operations, Significa

Nature of Operations, Significant Accounting Policies and Going Concern	4 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN	1. NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN Nature of Business Operations Bespoke Extracts, Inc. (the “Company”) is a Nevada corporation focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. In November 2021, new management of the Company was appointed and the Company began to focus on other complimentary lines of business to its CBD offerings. Under our new management team, we plan to expand the Company’s focus to regulated cannabis markets in the United States. On December 2, 2021, Bespoke Extracts Colorado, LLC (“Bespoke Colorado”), a newly formed wholly-owned subsidiary of the Company entered into an asset purchase agreement with WonderLeaf, LLC (“WonderLeaf”), and on December 7, 2021, Bespoke Colorado and WonderLeaf entered into an amendment to such asset purchase agreement (as amended, the “WonderLeaf Purchase Agreement”). Pursuant to the Wonderleaf Purchase Agreement, Bespoke Colorado agreed to purchase from WonderLeaf, and WonderLeaf agreed to sell to Bespoke Colorado, certain assets of WonderLeaf, including a license to manufacture marijuana-infused products, existing inventory, and extraction equipment and ancillary items, all as further set forth in the Wonderleaf Purchase Agreement, for a purchase price of $225,000, to be paid in shares of common stock of the Company (including 2,500,000 shares issuable, and to be held in escrow, upon execution of the WonderLeaf Purchase Agreement, and an additional $150,000 of common stock that will be valued based on the volume weighted average price of the common stock, subject to a floor of $0.02 per share and a ceiling of $0.04 per share), provided that, the purchase price for the inventory will be 90% of the wholesale value of the regulated marijuana portion of the inventory and the packaging corresponding thereto set forth on the inventory accounting statement to be prepared pursuant to the Wonderleaf Purchase Agreement. As of the date of filing the Company has not closed on the transaction. Basis of Presentation The accompanying condensed consolidated unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. For further information, refer to the Company’s financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2021. On February 2, 2022, the Company changed its fiscal year from August 31 to December 31. Certain prior period amounts have been reclassified to conform to the current period presentation. Principles of Consolidation The accompanying condensed consolidated unaudited financial statements include the accounts of Bespoke Extracts Inc, and its wholly owned subsidiary Bespoke Extracts Colorado, LLC. All inter-company balances have been eliminated. Going Concern The accompanying condensed consolidated unaudited financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit as of and for the four months ended December 31, 2021. This raises substantial doubt about our ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates. Cash and Cash Equivalents Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At December 31, 2021 and August 31, 2021, the Company did not have any cash equivalents. Fair Value of Financial Instruments The carrying amounts of cash, accounts receivable, prepaid expenses, inventory and other assets, accounts payable, accrued liabilities, note payable and convertible note payable approximate their fair values as of December 31, 2021 and August 31, 2021, respectively, because of their short-term natures and the Company’s borrowing rate of interest. Accounts Receivable Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense. The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At December 31, 2021 and August 31, 2021, the Company has recorded an allowance for doubtful accounts of $0 and $2,981, respectively. At December 31, 2021 and August 31, 2021 included in the accounts receivable is the merchant holdback receivable balance of $3,636 and $3,636, respectively which will be remitted to the Company in the future. Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of December 31, 2021 and August 31, 2021, inventory amounted to $46,825 and $48,259, respectively, which consisted of finished goods of $43,574 and $45,008, and raw materials of $3,251 and, $3,251 net of reserves, respectively. As of December 31, 2021 and August 31, 2021 inventory reserves were $33,476 and $33,476, respectively. Revenue Recognition We account for revenue in accordance with the Financial Accounting Standards Board (“FASB”) Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 30 day return policy on sales. Stock Based Compensation Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718 , Compensation-Stock Compensation, Net Income / (Loss) per Share Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. The effect of 15,500,000 warrants and 46,072,874 options is anti-dilutive for the four months ended December 31, 2021 as they are not in the money. The effect of 3,150,000 warrants and 0 options is anti-dilutive for the four months ended December 31, 2020 as well as 500,000,000 shares issuable upon the conversion of a convertible note. Recent accounting pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company as of the specified effective date. Income Taxes We utilize the asset and liability method of accounting for income taxes. We recognize deferred tax liabilities or assets for the expected future tax consequences of temporary differences between the book and tax basis of assets and liabilities. We regularly assess the likelihood that our deferred tax assets will be recovered from future taxable income. We consider projected future taxable income and ongoing tax planning strategies in assessing the amount of the valuation allowance necessary to offset our deferred tax assets that will not be recoverable. We have recorded and continue to carry a full valuation allowance against our gross deferred tax assets that will not reverse against deferred tax liabilities within the scheduled reversal period. If we determine in the future that it is more likely than not that we will realize all or a portion of our deferred tax assets, we will adjust our valuation allowance in the period we make the determination. We expect to provide a full valuation allowance on our future tax benefits until we can sustain a level of profitability that demonstrates our ability to realize these assets.

Asset Purchase Agreement

Asset Purchase Agreement	4 Months Ended
	Dec. 31, 2021
Asset Purchase Agreement [Abstract]
ASSET PURCHASE AGREEMENT	2. ASSET PURCHASE AGREEMENT On February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain domain names set forth in an asset purchase agreement for a total of $20,185 in cash and 200,000 shares of the Company’s common stock valued at $30,000. During the year ended August 31, 2020, the Company transferred certain URLs valued at $5,282 to an unrelated party and impaired $289 leaving a balance of $44,614 of URL’s. The domain names are being amortized over a 15 year period. During the year ended August 31, 2021, the Company recorded an amortization expense of $3,244. During the year ended August 31, 2020, the Company recorded an impairment expense of $289 for the expired domain names. During the four months ended December 31, 2021 and 2020, the Company recorded an amortization expense of $0 and $811, respectively. In connection with a stock purchase agreement (see note 7), on October 28, 2021, a convertible debenture with an original issue date of December 24, 2019, as amended by Amendment No. 1 thereto, dated May 28, 2020, Amendment No. 2 thereto, dated August 21, 2020, Amendment No. 3 thereto, dated December 10, 2020, Amendment No. 4 thereto, dated January 15, 2021, Amendment No. 5 thereto, dated April 2, 2021, and Amendment No. 6 thereto, dated August 2, 2021 (as amended, the “Debenture”) with an original principal amount of approximately $400,000 was terminated, and all amounts due and payable thereunder forgiven pursuant to a cancellation and satisfaction of debenture agreement entered into between the Company and the Debenture holder. In exchange for cancellation of the debt owed under the Debenture, the Company transferred to the holder certain domain names valued at $32,748. (See Notes 3 and 5.)

Inventory Earned-Out

Inventory Earned-Out	4 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
INVENTORY EARNED-OUT	3. INVENTORY EARNED-OUT As described in Notes 2 and 5, in exchange for cancellation of the debt owed under the Debenture, the Company transferred to the holder certain domain names and agreed to pay the holder, beginning December 1, 2021, and on a monthly basis through August 31, 2022, 40% of the operating profit generated from sale of the existing CBD inventory of the Company, and on August 31, 2022, to make a final payment equal to an amount of $75,000 minus the total of the monthly payments made under the Inventory Earn Out.

Note Payable - Related Party

Note Payable - Related Party	4 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
NOTE PAYABLE - RELATED PARTY	4. NOTE PAYABLE - RELATED PARTY During the four months ended December 31, 2021, Danil Pollack, the Company’s former chief executive officer, forgave a note payable in the amount of $534. The amount was treated as a capital contribution. During the four months ended December 31, 2021, Michael Feinsod, the Company’s chief executive officer, loaned the Company a total of $62,500. The loan does not bear interest and is payable on demand. As of December 31, 2021 $60,000 had been repaid and $2,500 remains owed.

Convertible Note Payable

Convertible Note Payable	4 Months Ended
	Dec. 31, 2021
Convertible Debenture Related Party [Abstract]
CONVERTIBLE NOTE PAYABLE	5. CONVERTIBLE NOTE PAYABLE On December 24, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock valued at $55,000 ($0.005 per share). The Company recorded beneficial conversion of $245,000 due to the conversion feature. The debenture could not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The debenture had an original maturity date of April 30, 2020 and was convertible into shares of common stock of the Company at an initial conversion price of $0.001, except that, if the Company failed to repay the debenture upon maturity, the conversion price would be reduced to $0.0004 (subject to adjustment for stock splits, stock dividends, and similar transactions) and the debenture would bear interest at the rate of 9% per year. The Company’s obligation to repay the debenture upon maturity was initially secured by a security interest in the Company’s inventory pursuant to a security agreement between the Company and the investor. For the year ended August 31, 2020 the Company recorded amortization of debt discount of $500,000. A portion of the debenture was subsequently sold by the original purchaser to a third party. On April 23, 2020, the Company entered into an amendment to the security agreement with the holders of the debentures. Pursuant to the security agreement amendment, the collateral under the security agreement was amended to be the Company’s URLs. The Company also entered into six amendments to the debentures, including to increase the conversion price to $0.05, and to extend the maturity date, including an amendment entered into on August 2, 2021, to extend the maturity date to August 31, 2021. In September 2021, a debenture holder converted $100,000 into 2,000,000 shares of common stock at a price of $0.05 per share. On October 28, 2021, in connection with a stock purchase agreement, the Debenture with an original principal amount of approximately $400,000 was terminated, and all amounts due and payable thereunder forgiven pursuant to a cancellation and satisfaction of debenture agreement entered into between the Company and the Debenture holder. In exchange for cancellation of the debt owed under the Debenture, the Company transferred to the holder certain domain names valued at $32,748 and agreed to pay the holder, beginning December 1, 2021, and on a monthly basis through August 31, 2022, 40% of the operating profit generated from sale of the existing CBD inventory of the Company, and on August 31, 2022, to make a final payment equal to an amount of $75,000 minus the total of the monthly payments made under the Inventory Earn Out. The Company recorded a gain on the extinguishment of debt $292,252.

Leases

Leases	4 Months Ended
	Dec. 31, 2021
Disclosure [Abstract]
LEASES	6. LEASES In connection with the Wonderleaf Purchase Agreement, Bespoke Colorado entered into a lease agreement (the “Lease”) with WL Holdings, Ltd. (“WL Holdings”) Pursuant to the Lease, Bespoke Colorado will lease from WL Holdings certain commercial space in Aurora, Colorado, where WonderLeaf’s business has been located, commencing upon signing of the Lease and Wonderleaf Purchase Agreement, for a term of five years, which Bespoke Colorado will have an option to renew for an additional five years. Monthly rent under the Lease will start at $6,000. Supplemental balance sheet information related to leases was as follows: December 31, Operating Leases Classification 2021 Right-of-use assets Right of use assets $ 339,780 Current lease liabilities Current operating lease liabilities 59,777 Non-current lease liabilities Long-term operating lease liabilities 280,369 Total lease liabilities $ 340,146 Lease term and discount rate were as follows: December 31, 2021 Weighted average remaining lease term (years) 4.92 Weighted average discount rate 4 % The component of lease costs was as follows: Four months December 31, 2021 Operating lease cost $ 6,366 Variable lease cost (1) - Total lease costs $ 6,366 (1) Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate. Supplemental disclosures of cash flow information related to leases were as follows: December 31, 2021 Cash paid for operating lease liabilities $ 6,000 Right of use assets obtained in exchange for operating lease liabilities $ 344,996 Maturities of lease liabilities were as follows as of December 31, 2021: Operating Leases 2022 $ 72,300 2023 75,600 2024 75,915 2025 79,380 2026 72,765 Thereafter - Total undiscounted lease payments 375,960 Less: Present value discount (35,814 ) Total Present value of lease liabilities $ 340,146

Equity

Equity	4 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
EQUITY	7. EQUITY Common Stock and Preferred Stock As of August 31, 2020, the Company had authorized capital of 800,000,000 shares of common stock with a par value of $0.001, and 50,000,000 shares of preferred stock with a par value of $0.001. On October 2, 2020, the Company filed a certificate of amendment to the Company’s articles of incorporation with the Secretary of State of Nevada, pursuant to which the Company increased its authorized shares of common stock from 800,000,000 to 3,000,000,000. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock. No shares of Series A Preferred Stock are issued and outstanding as of December 31, 2021 and August 31, 2021 respectively. The Company’s Certificate of Designation of Series B Preferred Stock was withdrawn by the Company on June 30, 2020. 1 share of preferred stock is designated Series C Preferred Stock and is issued and outstanding as of December 31, 2021 and August 31, 2021, respectively. The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company’s stockholders. The Company may, in its sole discretion, redeem the Series C Preferred Stock at any time for a redemption price equal to the stated value. Upon payment of the redemption price by the Company, the Series C Preferred Stock will revert to the status of authorized but unissued preferred stock. In September 2021 a debenture holder converted $100,000 of a convertible debenture into 2,000,000 shares of common stock at a price of $0.05 per share. (See Note 5.) On October 28, 2021, the Company entered into a stock purchase agreement with Danil Pollack (the Company’s then-chief executive officer), and Infinity Management, LLC (‘Infinity”). Pursuant to the purchase agreement, upon the closing thereof on November 19, 2021, Mr. Pollack sold to Infinity, 50,000,000 shares of the common stock of the Company and one share of Series C preferred stock of the Company for cash consideration of $40,000. The Series C Preferred Stock Infinity acquired represents 51% of the voting power of the Company’s capital stock, and therefore the transaction resulted in a change-in-control of the Company. The purchase agreement further provided for Infinity to make a capital contribution to the Company of $4,792 to cover payment of the amounts due to certain creditors of the Company, as set forth in the purchase agreement. The amount was paid on January 18, 2022. In connection with the purchase agreement, and effective upon the closing thereunder, Michael Feinsod, the managing member of Infinity, was appointed as the chief executive officer and chairman of the board of directors of the Company, Mr. Hunter Garth was appointed as a director, as well as chief strategy officer of the Company, and Mr. Pollack resigned from all positions with the Company, including as president, CEO, chief financial officer and director. During the four months ended December 31, 2021, the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of 50,000,000 shares of common stock and warrants to purchase an aggregate of 12,500,000 shares of common stock, for an aggregate purchase price of $250,000 with offering costs of $10,000 for legal expenses. The warrants have a term of one year and an exercise price of $0.05. On December 2, 2021, Bespoke Colorado, a newly formed wholly-owned subsidiary of the Company entered into an asset purchase agreement with WonderLeaf, LLC (“WonderLeaf”), and on December 7, 2021, Bespoke Colorado and WonderLeaf entered into an amendment to such asset purchase agreement (as amended, the “WonderLeaf Purchase Agreement”). Pursuant to the Wonderleaf Purchase Agreement, Bespoke Colorado agreed to purchase from WonderLeaf, and WonderLeaf agreed to sell to Bespoke Colorado, certain assets of WonderLeaf, including a license to manufacture marijuana-infused products, existing inventory, and extraction equipment and ancillary items, all as further set forth in the Wonderleaf Purchase Agreement, for a purchase price of $225,000, to be paid in shares of common stock of the Company (including 2,500,000 shares issuable, and to be held in escrow, upon execution of the Purchase Agreement, and an additional $150,000 of common stock that will be valued based on the volume weighted average price of the common stock, subject to a floor of $0.02 per share and a ceiling of $0.04 per share), provided that, the purchase price for the inventory will be 90% of the wholesale value of the regulated marijuana portion of the inventory and the packaging corresponding thereto set forth on the inventory accounting statement to be prepared pursuant to the Wonderleaf Purchase Agreement, As of the date of filing the Company has not closed on the transaction. On December 14, 2021, the board of directors of the Company adopted the Company’s 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which up to an aggregate of 300,000,000 shares of common stock are available for issuance. Awards under the plan may include options (including incentive stock options and non-qualified stock options), stock appreciation rights, restricted stock, restricted stock units, performance share awards, or other equity-based awards, each as defined under the 2021 Plan. Options awarded under the 2021 Plan are to have an exercise price of not less than 100% of the fair market value of the common stock on the grant date and a term of not more than ten years from the option grant date. On December 14, 2021, the Company entered into an employment agreement with Hunter Garth. Pursuant to the employment agreement, Mr. Garth will serve as the Company’s president and will receive a base monthly salary of $8,000. The Company also granted to Mr. Garth, pursuant to the Company’s newly adopted 2021 Equity Incentive Plan, 22,500,000 shares of restricted common stock valued at $675,000 ($0.03 per share), which will vest one year from the date of grant. During the four months ended December 31, 2021 the Company recorded $31,439 of expenses associated with the stock based compensation. On December 14, 2021, the Company entered into an employment agreement with Michael Feinsod, the Company’s chief executive officer and chairman. Pursuant to the employment agreement, Mr. Garth will continue to serve as the Company’s chief executive officer and chairman and will receive a base monthly salary of $10,000. The Company also granted to Mr. Feinsod, pursuant to the Company’s newly adopted 2021 Equity Incentive Plan, 45,000,000 shares of restricted common stock valued at $1,350,000 ($0.03 per share), which will vest one year from the date of grant. During the four months ended December 31, 2021 the Company recorded $62,822 of expenses associated with the stock based compensation. On December 24, 2021 the Company issued 291,498 shares of common stock valued at $7,987 ($.0274 per share) for services. Warrants During the four months ended December 31, 2021, the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of 50,000,000 shares of common stock and warrants to purchase an aggregate of 12,500,000 shares of common stock, for an aggregate purchase price of $250,000 with offering costs of $10,000 for legal expenses. The warrants have a term of one year and an exercise price of $0.05. The following table summarizes the warrant activities during the four months ended December 31, 2021: Number of Weighted- Weighted- Outstanding at August 31, 2021 3,000,000 $ 0.52 2.16 years Granted 12,500,000 0.05 1.0 years Canceled or expired - - Exercised - - Outstanding at December 31, 2021 15,500,000 $ 0.14 1.15 years Exercisable at December 31, 2021 15,500,000 $ 0.14 1.15 years Intrinsic value at December 31, 2021 $ - Options On December 14, 2021, the Company entered into an employment agreement with Hunter Garth. Pursuant to the employment agreement, Mr. Garth will serve as the Company’s president and will receive a base monthly salary of $8,000. The Company also granted to Mr. Garth, pursuant to the Company’s newly adopted 2021 Equity Incentive Plan, ten-year options to purchase 15,000,000 shares of common stock at an exercise price of $0.06 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. The options were valued at $450,000 using a Black-Scholes pricing model. During the four months ended December 31, 2021 the Company recorded $12,806 of expenses associated with the vesting of these stock options. On December 14, 2021, the Company entered into an employment agreement with Michael Feinsod, the Company’s chief executive officer and chairman. Pursuant to the employment agreement, Mr. Garth will continue to serve as the Company’s chief executive officer and chairman and will receive a base monthly salary of $10,000. The Company also granted to Mr. Feinsod, pursuant to the Company’s newly adopted 2021 Equity Incentive Plan, ten-year options to purchase 30,000,000 shares of common stock at an exercise price of $0.06 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. The Options were valued at $900,000 using a black-scholes pricing model. During the four months ended December 31, 2021 the Company recorded $29,140 of expenses associated with the vesting of these stock options. On December 14, 2021 Company issued to a consultant options to purchase 1,000,000 shares of common stock at an exercise price of $0.03. The options vest over a period of 3 months and have life of 10 years. The options were valued at $30,000 using a Black-Scholes pricing model. During the four months ended December 31, 2021 the Company recorded $5,100 of expenses associated with the vesting of these stock options. On December 24, 2021 the Company issued options to purchase 72,874 shares of common stock at an exercise price of $0.0274. The options vest immediately and have life of 5 years. The options were valued at $1,997 using a Black-Scholes pricing model. During the four months ended December 31, 2021 the Company recorded $1,997 of expenses associated with the vesting of these stock options. The following table summarizes the option activities during the four months ended December 31, 2021: Number of Weighted- Weighted- Outstanding at August 31, 2021 - $ - Granted 46,072,874 0.06 10.00 years Canceled or expired - - Exercised - - Outstanding at December 31, 2021 46,072,874 $ 0.06 9.95 years Exercisable at December 31, 2021 72,874 $ 0.027 5.98 years Intrinsic value at December 31, 2021 $ 189 The estimated fair value of each stock option grant on the date of grant was computed using the following weighted-average assumptions: December 31, 2021 Risk-free interest rate 1.23 % Expected term (life) of options (in years) 5 Expected dividends — Expected volatility 368 %

Related Party Transactions

Related Party Transactions	4 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	8. RELATED PARTY TRANSACTIONS On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack’s appointment, the Company entered into an employment agreement with Mr. Pollack. Pursuant to the employment agreement, Mr. Pollack agreed to serve as the Company’s chief executive officer and president for a period of one year, which term would renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. On September 30, 2020, the Company entered into an amendment to the Company’s employment agreement, dated April 22, 2020, with Danil Pollack, the Company’s then-chief executive officer. Pursuant to the amendment, the Company agreed to pay Mr. Pollack an annual salary of $48,000. On April 27, 2021, the Company entered into an amendment to the Company’s employment agreement with Mr. Pollack. Pursuant to the amendment, the Company agreed to pay Mr. Pollack an annual salary of $66,000 effective April 1, 2021. The Company could also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus. On November 2, 2021, effective July 1, 2021 Mr. Pollack waived all compensation owed to him by the Company as of such date through the date of his resignation as the Company’s chief executive officer. Mr. Pollack elected to forgive $11,000 of salary during four months ended December 31, 2021, and the amount was recorded as a capital contribution. On October 28, 2021, the Company entered into a stock purchase agreement with Danil Pollack (the Company’s then-chief executive officer), and Infinity Management, LLC (‘Infinity”). Pursuant to the purchase agreement, upon the closing thereof on November 19, 2021, Mr. Pollack sold to Infinity, 50,000,000 shares of the common stock of the Company and one share of Series C preferred stock of the Company for cash consideration of $40,000. The Series C Preferred Stock Infinity acquired represents 51% of the voting power of the Company’s capital stock, and therefore the transaction resulted in a change-in-control of the Company. The purchase agreement further provided for Infinity to make a capital contribution to the Company of $4,792 to cover payment of the amounts due to certain creditors of the Company, as set forth in the purchase agreement. The amount was paid on January 18, 2022. In connection with the purchase agreement, and effective upon the closing thereunder, Mr. Michael Feinsod, the managing member of Infinity, was appointed as the chief executive officer and chairman of the board of directors of the Company, Mr. Hunter Garth was appointed as a director, as well as chief strategy officer of the Company, and Mr. Pollack resigned from all positions with the Company, including as president, CEO, chief financial officer and director of the Company. On December 14, 2021, the Company entered into an employment agreement with Hunter Garth. Pursuant to the employment agreement, Mr. Garth will serve as the Company’s president and will receive a base monthly salary of $8,000. The Company also granted to Mr. Garth, pursuant to the Company’s newly adopted 2021 Equity Incentive Plan, 22,500,000 shares of restricted common stock, which will vest one year from the date of grant, and ten-year options to purchase 15,000,000 shares of common stock at an exercise price of $0.06 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. In the event that Mr. Garth is terminated without cause or resigns with good reason (each as defined in the employment agreement), he will be entitled to his monthly base salary for twelve months following such termination. (See notes 7 and 9). On December 14, 2021, the Company entered into an employment agreement with Michael Feinsod, the Company’s chief executive officer and chairman. Pursuant to the employment agreement, Mr. Garth will continue to serve as the Company’s chief executive officer and chairman and will receive a base monthly salary of $10,000. The Company also granted to Mr. Feinsod, pursuant to the Company’s newly adopted 2021 Equity Incentive Plan, 45,000,000 shares of restricted common stock, which will vest one year from the date of grant, and ten-year options to purchase 30,000,000 shares of common stock at an exercise price of $0.06 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. In the event that Mr. Feinsod is terminated without cause or resigns with good reason (each as defined in the employment agreement), he will be entitled to his monthly base salary for twelve months following such termination. (See notes 7 and 9). During the four months ended December 31, 2021, Michael Feinsod, the Company’s chief executive officer, loaned the Company a total of 62,500. The loan does not bear interest and is payable on demand. As of December 31, 2021 $60,000 had been repaid. During the four months ended December 31, 2021, Danil Pollack, the Company’s former chief executive officer forgave a note payable in the amount of $534. The Amount was treated as a capital contribution.

Commitments and Contingencies

Commitments and Contingencies	4 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	9 . COMMITMENTS AND CONTINGENCIES On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack’s appointment, the Company entered into an employment agreement with Mr. Pollack. On September 30, 2020, the Company entered into an amendment to the employment agreement. Pursuant to the amendment, the Company agreed to pay Mr. Pollack an annual salary of $48,000. On April 27, 2021, the Company entered into an amendment to the Company’s employment agreement with Mr. Pollack. Pursuant to the amendment, the Company agreed to pay Mr. Pollack an annual salary of $66,000 effective April 1, 2021. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus. Mr. Pollack elected to forgive $11,000 of salary during four months ended December 31, 2021, the amount was recorded as a capital contribution. In connection with the purchase agreement, a convertible debenture with an original issue date of December 24, 2019, as amended by Amendment No. 1 thereto, dated May 28, 2020, Amendment No. 2 thereto, dated August 21, 2020, Amendment No. 3 thereto, dated December 10, 2020, Amendment No. 4 thereto, dated January 15, 2021, Amendment No. 5 thereto, dated April 2, 2021, and Amendment No. 6 thereto, dated August 2, 2021 (as amended, the “Debenture”) with an original principal amount of approximately $400,000 was terminated, and all amounts due and payable thereunder forgiven pursuant to a cancellation and satisfaction of debenture agreement entered into between the Company and the Debenture holder (the “Debt Cancellation Agreement”). In exchange for cancellation of the debt owed under the Debenture, the Company transferred to the holder certain domain names and agreed to pay the holder, beginning December 1, 2021, and on a monthly basis through August 31, 2022, 40% of the operating profit generated from sale of the existing CBD inventory of the Company (the “Inventory Earn Out”), and on August 31, 2022, to make a final payment equal to an amount of $75,000 minus the total of the monthly payments made under the Inventory Earn Out. (See notes 3 and 5). On December 14, 2021, the Company entered into an employment agreement with Hunter Garth. Pursuant to the employment agreement, Mr. Garth will serve as the Company’s president and will receive a base monthly salary of $8,000. The Company also granted to Mr. Garth, pursuant to the Company’s newly adopted 2021 Equity Incentive Plan, 22,500,000 shares of restricted common stock, which will vest one year from the date of grant, and ten-year options to purchase 15,000,000 shares of common stock at an exercise price of $0.06 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. In the event that Mr. Garth is terminated without cause or resigns with good reason (each as defined in the employment agreement), he will be entitled to his monthly base salary for twelve months following such termination. (See notes 7 and 8). On December 14, 2021, the Company entered into an employment agreement with Michael Feinsod, the Company’s chief executive officer and chairman. Pursuant to the employment agreement, Mr. Garth will continue to serve as the Company’s chief executive officer and chairman and will receive a base monthly salary of $10,000. The Company also granted to Mr. Feinsod, pursuant to the Company’s newly adopted 2021 Equity Incentive Plan, 45,000,000 shares of restricted common stock, which will vest one year from the date of grant, and ten-year options to purchase 30,000,000 shares of common stock at an exercise price of $0.06 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. In the event that Mr. Feinsod is terminated without cause or resigns with good reason (each as defined in the employment agreement), he will be entitled to his monthly base salary for twelve months following such termination. (See notes 7 and 8).

Major Customers

Major Customers	4 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
MAJOR CUSTOMERS	10. MAJOR CUSTOMERS At December 31, 2021 and August 31, 2021, no individual customer amounted to over 10% of total accounts receivable. During the four months ended December 31, 2021 and 2020, no individual customer amounted to over 10% of total sales.

Subsequent Events

Subsequent Events	4 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	11. SUBSEQUENT EVENTS On January 18, 2022 Infinity made a capital contribution to the Company of $4,792 to cover payment of the amounts due to certain creditors of the Company. On January 18, 2022, the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of 15,850,000 shares of common stock and warrants to purchase an aggregate of 3,962,500 shares of common stock, for an aggregate purchase price of $79,250. The warrants have a term of one year and an exercise price of $0.05. On January 19, 2022 the Company loaned WonderLeaf $10,000, pursuant to a Promissory Note. The Note bears interest at 5.0% annually and matures on January 18, 2023 On February 8, 2022 the Company loaned WonderLeaf $10,000, pursuant to a Promissory Note. The Note bears interest at 5.0% annually and matures on February 8, 2023. On February 2, 2022, the Company changed its fiscal year from August 31 to December 31. On March 21, 2022, the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of 3,000,000 shares of common stock and warrants to purchase an aggregate of 750,000 shares of common stock, for an aggregate purchase price of $15,000. The warrants have a term of one year and an exercise price of $0.05.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	4 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Nature of Business Operations	Nature of Business Operations Bespoke Extracts, Inc. (the “Company”) is a Nevada corporation focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. In November 2021, new management of the Company was appointed and the Company began to focus on other complimentary lines of business to its CBD offerings. Under our new management team, we plan to expand the Company’s focus to regulated cannabis markets in the United States. On December 2, 2021, Bespoke Extracts Colorado, LLC (“Bespoke Colorado”), a newly formed wholly-owned subsidiary of the Company entered into an asset purchase agreement with WonderLeaf, LLC (“WonderLeaf”), and on December 7, 2021, Bespoke Colorado and WonderLeaf entered into an amendment to such asset purchase agreement (as amended, the “WonderLeaf Purchase Agreement”). Pursuant to the Wonderleaf Purchase Agreement, Bespoke Colorado agreed to purchase from WonderLeaf, and WonderLeaf agreed to sell to Bespoke Colorado, certain assets of WonderLeaf, including a license to manufacture marijuana-infused products, existing inventory, and extraction equipment and ancillary items, all as further set forth in the Wonderleaf Purchase Agreement, for a purchase price of $225,000, to be paid in shares of common stock of the Company (including 2,500,000 shares issuable, and to be held in escrow, upon execution of the WonderLeaf Purchase Agreement, and an additional $150,000 of common stock that will be valued based on the volume weighted average price of the common stock, subject to a floor of $0.02 per share and a ceiling of $0.04 per share), provided that, the purchase price for the inventory will be 90% of the wholesale value of the regulated marijuana portion of the inventory and the packaging corresponding thereto set forth on the inventory accounting statement to be prepared pursuant to the Wonderleaf Purchase Agreement. As of the date of filing the Company has not closed on the transaction.
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. For further information, refer to the Company’s financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2021. On February 2, 2022, the Company changed its fiscal year from August 31 to December 31. Certain prior period amounts have been reclassified to conform to the current period presentation.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated unaudited financial statements include the accounts of Bespoke Extracts Inc, and its wholly owned subsidiary Bespoke Extracts Colorado, LLC. All inter-company balances have been eliminated.
Going Concern	Going Concern The accompanying condensed consolidated unaudited financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit as of and for the four months ended December 31, 2021. This raises substantial doubt about our ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At December 31, 2021 and August 31, 2021, the Company did not have any cash equivalents.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts of cash, accounts receivable, prepaid expenses, inventory and other assets, accounts payable, accrued liabilities, note payable and convertible note payable approximate their fair values as of December 31, 2021 and August 31, 2021, respectively, because of their short-term natures and the Company’s borrowing rate of interest.
Accounts Receivable	Accounts Receivable Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense. The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At December 31, 2021 and August 31, 2021, the Company has recorded an allowance for doubtful accounts of $0 and $2,981, respectively. At December 31, 2021 and August 31, 2021 included in the accounts receivable is the merchant holdback receivable balance of $3,636 and $3,636, respectively which will be remitted to the Company in the future.
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of December 31, 2021 and August 31, 2021, inventory amounted to $46,825 and $48,259, respectively, which consisted of finished goods of $43,574 and $45,008, and raw materials of $3,251 and, $3,251 net of reserves, respectively. As of December 31, 2021 and August 31, 2021 inventory reserves were $33,476 and $33,476, respectively.
Revenue Recognition	Revenue Recognition We account for revenue in accordance with the Financial Accounting Standards Board (“FASB”) Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 30 day return policy on sales.
Stock Based Compensation	Stock Based Compensation Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718 , Compensation-Stock Compensation,
Net Income / (Loss) per Share	Net Income / (Loss) per Share Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. The effect of 15,500,000 warrants and 46,072,874 options is anti-dilutive for the four months ended December 31, 2021 as they are not in the money. The effect of 3,150,000 warrants and 0 options is anti-dilutive for the four months ended December 31, 2020 as well as 500,000,000 shares issuable upon the conversion of a convertible note.
Recent Accounting Pronouncements	Recent accounting pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company as of the specified effective date.
Income Taxes	Income Taxes We utilize the asset and liability method of accounting for income taxes. We recognize deferred tax liabilities or assets for the expected future tax consequences of temporary differences between the book and tax basis of assets and liabilities. We regularly assess the likelihood that our deferred tax assets will be recovered from future taxable income. We consider projected future taxable income and ongoing tax planning strategies in assessing the amount of the valuation allowance necessary to offset our deferred tax assets that will not be recoverable. We have recorded and continue to carry a full valuation allowance against our gross deferred tax assets that will not reverse against deferred tax liabilities within the scheduled reversal period. If we determine in the future that it is more likely than not that we will realize all or a portion of our deferred tax assets, we will adjust our valuation allowance in the period we make the determination. We expect to provide a full valuation allowance on our future tax benefits until we can sustain a level of profitability that demonstrates our ability to realize these assets.

Leases (Tables)

Leases (Tables)	4 Months Ended
	Dec. 31, 2021
Disclosure Text Block [Abstract]
Schedule of supplemental balance sheet information	December 31, Operating Leases Classification 2021 Right-of-use assets Right of use assets $ 339,780 Current lease liabilities Current operating lease liabilities 59,777 Non-current lease liabilities Long-term operating lease liabilities 280,369 Total lease liabilities $ 340,146
Schedule of lease term and discount rate	December 31, 2021 Weighted average remaining lease term (years) 4.92 Weighted average discount rate 4 %
Schedule of lease costs	Four months December 31, 2021 Operating lease cost $ 6,366 Variable lease cost (1) - Total lease costs $ 6,366 (1) Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate.
Schedule of cash flow information related to leases	December 31, 2021 Cash paid for operating lease liabilities $ 6,000 Right of use assets obtained in exchange for operating lease liabilities $ 344,996
Schedule of maturities of lease liabilities	Operating Leases 2022 $ 72,300 2023 75,600 2024 75,915 2025 79,380 2026 72,765 Thereafter - Total undiscounted lease payments 375,960 Less: Present value discount (35,814 ) Total Present value of lease liabilities $ 340,146

Equity (Tables)

Equity (Tables)	4 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Schedule of warrants	Number of Weighted- Weighted- Outstanding at August 31, 2021 3,000,000 $ 0.52 2.16 years Granted 12,500,000 0.05 1.0 years Canceled or expired - - Exercised - - Outstanding at December 31, 2021 15,500,000 $ 0.14 1.15 years Exercisable at December 31, 2021 15,500,000 $ 0.14 1.15 years Intrinsic value at December 31, 2021 $ -
Schedule of stock options	Number of Weighted- Weighted- Outstanding at August 31, 2021 - $ - Granted 46,072,874 0.06 10.00 years Canceled or expired - - Exercised - - Outstanding at December 31, 2021 46,072,874 $ 0.06 9.95 years Exercisable at December 31, 2021 72,874 $ 0.027 5.98 years Intrinsic value at December 31, 2021 $ 189
Schedule of estimated fair value of each stock option grant	December 31, 2021 Risk-free interest rate 1.23 % Expected term (life) of options (in years) 5 Expected dividends — Expected volatility 368 %

Nature of Operations, Signifi_2

Nature of Operations, Significant Accounting Policies and Going Concern (Details) - USD ($)	Dec. 02, 2021	Aug. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Nature of Operations, Significant Accounting Policies and Going Concern (Details) [Line Items]
Agreement purchase price	$ 225,000
Common stock including shares issuable (in Shares)	2,500,000
Additional common stock	$ 150,000
Price per share (in Dollars per share)	$ 0.04
Inventory purchase price, percentage	90.00%
Allowance for doubtful accounts		$ 2,981	$ 0
Accounts receivable		3,636	3,636
Inventory		48,259	46,825
Inventory finished goods		45,008	43,574
Raw material, net reserve		3,251	3,251
Inventory reserves		$ 33,476	$ 33,476
Anti-dilutive options (in Shares)			46,072,874
Shares issuable conversion of a convertible note (in Shares)				500,000,000
Common Stock [Member]
Nature of Operations, Significant Accounting Policies and Going Concern (Details) [Line Items]
Price per share (in Dollars per share)	$ 0.02
Warrant [Member]
Nature of Operations, Significant Accounting Policies and Going Concern (Details) [Line Items]
Shares warrants (in Shares)			15,500,000
Anti-dilutive shares of warrants and options (in Shares)				3,150,000
Options [Member]
Nature of Operations, Significant Accounting Policies and Going Concern (Details) [Line Items]
Anti-dilutive shares of warrants and options (in Shares)				0

Asset Purchase Agreement (Detai

Asset Purchase Agreement (Details) - USD ($)	Aug. 02, 2021	Dec. 31, 2021	Dec. 31, 2020	Aug. 31, 2021	Aug. 31, 2020	Feb. 21, 2017
Asset Purchase Agreement (Details) [Line Items]
Asset purchase agreement total						$ 20,185
Number of common stock shares (in Shares)						200,000
Common stock value						$ 30,000
Transferred value					$ 5,282
Impairment of unrelated party					289
Impaired of leaving balance					$ 44,614
Amortized over period					15 years
Amortization expense				$ 3,244
Transferred amount	$ 32,748
Asset Purchase Agreement [Member]
Asset Purchase Agreement (Details) [Line Items]
Amortization expense		$ 0	$ 811
Impairment leaving balance				$ 289
Original principal amount	$ 400,000

Inventory Earned-Out (Details)

Inventory Earned-Out (Details) - Forecast [Member]	Aug. 31, 2022USD ($)
Inventory Earned-Out (Details) [Line Items]
Operating profit, sale percentage	40.00%
Inventory earn out	$ 75,000

Note Payable - Related Party (D

Note Payable - Related Party (Details)	Dec. 31, 2021USD ($)
Note Payable - Related Party (Details) [Line Items]
Total loan	$ 62,500
Repaid	60,000
Remains owed	2,500
Chief Executive Officer [Member]
Note Payable - Related Party (Details) [Line Items]
Note payable	$ 534

Convertible Note Payable (Detai

Convertible Note Payable (Details) - USD ($)	Dec. 02, 2021	Aug. 31, 2021	Apr. 30, 2020	Aug. 31, 2022	Oct. 28, 2021	Sep. 30, 2021	Dec. 24, 2019	Aug. 31, 2022	Aug. 31, 2020	Aug. 02, 2021
Convertible Note Payable (Details) [Line Items]
Principal amount							$ 500,000
Purchase amount							$ 300,000
Issuance of common stock, shares (in Shares)							5,000,000
Common stock value							$ 55,000
Common stock per share price (in Dollars per share)							$ 0.005
Beneficial conversion feature							$ 245,000
Company outstanding percentage							4.99%
Extend maturity date		Aug. 31, 2021	Apr. 30, 2020
Conversion price (in Dollars per share)							$ 0.001			$ 0.05
Conversion price reduced per share (in Dollars per share)							$ 0.0004
Percentage of interest rate							9.00%
Debenture holder converted amount						$ 100,000
Converted to shares of common stock (in Shares)						2,000,000
Common stock price per share (in Dollars per share)						$ 0.05
Principal amount					$ 400,000
Debenture holder amount	$ 32,748
Securities Purchase Agreement [Member]
Convertible Note Payable (Details) [Line Items]
Amortization of debt discount									$ 500,000
Forecast [Member]
Convertible Note Payable (Details) [Line Items]
Percentage of operating profit generated								40.00%
Total of the monthly payments				$ 75,000				$ 75,000
Gain (Loss) on extinguishment of debt				$ 292,252

Leases (Details)

Leases (Details)	4 Months Ended
	Dec. 31, 2021USD ($)
Disclosure Text Block [Abstract]
Lease term	5 years
Renew for an additional term	5 years
Rent amount (in Dollars)	$ 6,000

Leases (Details) - Schedule of

Leases (Details) - Schedule of supplemental balance sheet information	4 Months Ended
	Dec. 31, 2021USD ($)
Schedule of supplemental balance sheet information [Abstract]
Right-of-use assets, Classification	Right of use assets
Right-of-use assets	$ 339,780
Current lease liabilities, Classification	Current operating lease liabilities
Current lease liabilities	$ 59,777
Non-current lease liabilities, Classification	Long-term operating lease liabilities
Non-current lease liabilities	$ 280,369
Total lease liabilities	$ 340,146

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of lease term and discount rate	Dec. 30, 2021
Schedule of lease term and discount rate [Abstract]
Weighted average remaining lease term (years)	4 years 11 months 1 day
Weighted average discount rate	4.00%

Leases (Details) - Schedule o_3

Leases (Details) - Schedule of lease costs	4 Months Ended
	Dec. 31, 2021USD ($)
Schedule of lease costs [Abstract]
Operating lease cost	$ 6,366
Variable lease cost		[1]
Total lease costs	$ 6,366
[1]	Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate.

Leases (Details) - Schedule o_4

Leases (Details) - Schedule of cash flow information related to leases	4 Months Ended
	Dec. 31, 2021USD ($)
Schedule of cash flow information related to leases [Abstract]
Cash paid for operating lease liabilities	$ 6,000
Right of use assets obtained in exchange for operating lease liabilities	$ 344,996

Leases (Details) - Schedule o_5

Leases (Details) - Schedule of maturities of lease liabilities	Dec. 31, 2021USD ($)
Schedule of maturities of lease liabilities [Abstract]
2022	$ 72,300
2023	75,600
2024	75,915
2025	79,380
2026	72,765
Thereafter
Total undiscounted lease payments	375,960
Less: Present value discount	(35,814)
Total Present value of lease liabilities	$ 340,146

Equity (Details)

Equity (Details) - USD ($)	Dec. 14, 2021	Dec. 13, 2021	Dec. 07, 2021	Oct. 02, 2020	Dec. 24, 2021	Oct. 28, 2021	Dec. 31, 2021	Sep. 30, 2021	Aug. 31, 2021	Aug. 31, 2020
Equity (Details) [Line Items]
Common stock, shares authorized (in Shares)							3,000,000,000		3,000,000,000	800,000,000
Common stock, par value (in Dollars per share)							$ 0.001		$ 0.001	$ 0.001
Preferred stock, shares authorized (in Shares)							50,000,000		50,000,000	50,000,000
Preferred stock, par value (in Dollars per share)							$ 0.001		$ 0.001	$ 0.001
Preferred stock, description				the Company filed a certificate of amendment to the Company’s articles of incorporation with the Secretary of State of Nevada, pursuant to which the Company increased its authorized shares of common stock from 800,000,000 to 3,000,000,000. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock.
Preferred stock stated value							$ 24,000
Voting power of percentage							51.00%
Common stock, description					On December 24, 2021 the Company issued options to purchase 72,874 shares of common stock at an exercise price of $0.0274. The options vest immediately and have life of 5 years. The options were valued at $1,997 using a Black-Scholes pricing model. During the four months ended December 31, 2021 the Company recorded $1,997 of expenses associated with the vesting of these stock options.		Company issued to a consultant options to purchase 1,000,000 shares of common stock at an exercise price of $0.03. The options vest over a period of 3 months and have life of 10 years. The options were valued at $30,000 using a Black-Scholes pricing model. During the four months ended December 31, 2021 the Company recorded $5,100 of expenses associated with the vesting of these stock options.
Sale of stock, number of shares issued (in Shares)					291,498
Offering costs							$ 250,000
Legal expenses							$ 10,000
Warrants term							1 year
Aggregate purchase price							$ 0.05
Purchase agreement, description			Pursuant to the Wonderleaf Purchase Agreement, Bespoke Colorado agreed to purchase from WonderLeaf, and WonderLeaf agreed to sell to Bespoke Colorado, certain assets of WonderLeaf, including a license to manufacture marijuana-infused products, existing inventory, and extraction equipment and ancillary items, all as further set forth in the Wonderleaf Purchase Agreement, for a purchase price of $225,000, to be paid in shares of common stock of the Company (including 2,500,000 shares issuable, and to be held in escrow, upon execution of the Purchase Agreement, and an additional $150,000 of common stock that will be valued based on the volume weighted average price of the common stock, subject to a floor of $0.02 per share and a ceiling of $0.04 per share), provided that, the purchase price for the inventory will be 90% of the wholesale value of the regulated marijuana portion of the inventory and the packaging corresponding thereto set forth on the inventory accounting statement to be prepared pursuant to the Wonderleaf Purchase Agreement, As of the date of filing the Company has not closed on the transaction.
Common stock value					$ 7,987
Common stock value, per share (in Dollars per share)					$ 274
Hunter Garth [Member]
Equity (Details) [Line Items]
Base monthly salary	$ 8,000
Michael Feinsod [Member]
Equity (Details) [Line Items]
Base monthly salary	10,000
Chief Executive Officer [Member]
Equity (Details) [Line Items]
Voting power of percentage						51.00%
Common stock, description						Pursuant to the purchase agreement, upon the closing thereof on November 19, 2021, Mr. Pollack sold to Infinity, 50,000,000 shares of the common stock of the Company and one share of Series C preferred stock of the Company for cash consideration of $40,000.
Infinity capital cover payment						$ 4,792
Series C Preferred Stock [Member]
Equity (Details) [Line Items]
Preferred stock, par value (in Dollars per share)							$ 0.001		$ 0.001
Preferred stock designated, shares issued (in Shares)							1		1
Preferred stock designated, shares outstanding (in Shares)							1		1
Equity Option [Member]
Equity (Details) [Line Items]
Base monthly salary	$ 10,000
Exercise price (in Dollars per share)							$ 0.027
Equity Option [Member] | Hunter Garth [Member]
Equity (Details) [Line Items]
Sale of stock, number of shares issued (in Shares)	15,000,000
Exercise price (in Dollars per share)	$ 0.06
Premium over closing price, percentage		120.00%
Options were valued							$ 450,000
Expenses associated with vesting stock options							12,806
2021 Equity Incentive Plan [Member]
Equity (Details) [Line Items]
Sale of stock, number of shares issued (in Shares)	300,000,000
Fair market value of common stock, percentage	100.00%
Option grant date term	10 years
2021 Equity Incentive Plan [Member] | Hunter Garth [Member]
Equity (Details) [Line Items]
Vesting period	1 year
Options were valued							450,000
2021 Equity Incentive Plan [Member] | Hunter Garth [Member] | Restricted Stock [Member]
Equity (Details) [Line Items]
Sale of stock, number of shares issued (in Shares)	22,500,000
Common stock value	$ 675,000
Common stock value, per share (in Dollars per share)	$ 0.03
2021 Equity Incentive Plan [Member] | Michael Feinsod [Member]
Equity (Details) [Line Items]
Sale of stock, number of shares issued (in Shares)	30,000,000
Vesting period	1 year
Exercise price (in Dollars per share)	$ 0.06
Premium over closing price, percentage		120.00%
Options were valued	$ 900,000
Expenses associated with vesting stock options							$ 29,140
2021 Equity Incentive Plan [Member] | Michael Feinsod [Member] | Restricted Stock [Member]
Equity (Details) [Line Items]
Sale of stock, number of shares issued (in Shares)	45,000,000
Common stock value	$ 1,350,000
Common stock value, per share (in Dollars per share)	$ 0.03
Common Stock [Member]
Equity (Details) [Line Items]
Sale of stock, number of shares issued (in Shares)							50,000,000
Common Stock [Member] | Investor [Member]
Equity (Details) [Line Items]
Sale of stock, number of shares issued (in Shares)							50,000,000
Common Stock [Member] | Chief Executive Officer [Member]
Equity (Details) [Line Items]
Convertible debenture								$ 100,000
Warrant to purchase of common stock (in Shares)								2,000,000
Exercise price (in Dollars per share)								$ 0.05
Warrant [Member]
Equity (Details) [Line Items]
Sale of stock, number of shares issued (in Shares)							12,500,000
Option grant date term							1 year 1 month 24 days
Exercise price (in Dollars per share)							$ 0.14
Warrant [Member] | Investor [Member]
Equity (Details) [Line Items]
Exercise price (in Dollars per share)							$ 0.05
Sale of stock, number of shares issued (in Shares)							12,500,000
Offering costs							$ 250,000
Legal expenses							$ 10,000
Warrants term							1 year

Equity (Details) - Schedule of

Equity (Details) - Schedule of warrants - Warrants [Member]	4 Months Ended
	Dec. 31, 2021$ / sharesshares
Class of Warrant or Right [Line Items]
Number of Warrants, Outstanding Beginning balance (in Shares) | shares	3,000,000
Weighted-Average Price Per Share, Outstanding Beginning balance	$ 0.52
Weighted- Average Remaining Life, Outstanding Beginning years	2 years 1 month 28 days
Number of Warrants, Granted (in Shares) | shares	12,500,000
Weighted-Average Price Per Share, Granted	$ 0.05
Weighted- Average Remaining Life, Granted	1 year
Number of Warrants, Cancelled or expired (in Shares) | shares
Weighted-Average Price Per Share, Cancelled or expired
Number of Warrants, Exercised (in Shares) | shares
Weighted-Average Price Per Share, Exercised / Exchanged
Number of Warrants, Outstanding Ending balance (in Shares) | shares	15,500,000
Weighted-Average Price Per Share, Outstanding Ending balance	$ 0.14
Weighted- Average Remaining Life, Outstanding Ending years	1 year 1 month 24 days
Number of Warrants, Exercisable (in Shares) | shares	15,500,000
Weighted-Average Price Per Share, Exercisable	$ 0.14
Weighted- Average Remaining Life, Exercisable	1 year 1 month 24 days
Weighted-Average Price Per Share Intrinsic value

Equity (Details) - Schedule o_2

Equity (Details) - Schedule of stock options - Options [Member]	4 Months Ended
	Dec. 31, 2021$ / sharesshares
Equity (Details) - Schedule of stock options [Line Items]
Number of Options, Outstanding Beginning balance (in Shares) | shares
Weighted-Average Price Per Share, Outstanding Beginning balance
Number of Options, Granted (in Shares) | shares	46,072,874
Weighted-Average Price Per Share, Granted	$ 0.06
Weighted- Average Remaining Life, Granted	10 years
Number of Options, Canceled or expired (in Shares) | shares
Weighted-Average Price Per Share, Canceled or expired
Number of Options, Exercised (in Shares) | shares
Weighted-Average Price Per Share, Exercised
Number of Options, Outstanding Ending balance (in Shares) | shares	46,072,874
Weighted-Average Price Per Share, Outstanding Ending balance	$ 0.06
Weighted- Average Remaining Life, Outstanding ending years	9 years 11 months 12 days
Number of Options, Exercisable (in Shares) | shares	72,874
Weighted-Average Price Per Share, Exercisable	$ 0.027
Weighted- Average Remaining Life, Exercisable	5 years 11 months 23 days
Weighted-Average Price Per Share Intrinsic value	$ 189

Equity (Details) - Schedule o_3

Equity (Details) - Schedule of estimated fair value of each stock option grant	4 Months Ended
	Dec. 31, 2021
Schedule of estimated fair value of each stock option grant [Abstract]
Risk-free interest rate	1.23%
Expected term (life) of options (in years)	5 years
Expected dividends
Expected volatility	368.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Dec. 14, 2021	Dec. 13, 2021	Apr. 01, 2021	Nov. 19, 2021	Sep. 30, 2020	Apr. 21, 2020	Dec. 31, 2021
Related Party Transactions (Details) [Line Items]
Shares of common stock (in Shares)						100,000,000
Purchase price per share (in Dollars per share)						$ 0.001
Cash consideration				$ 40,000
Capital contribution							$ 4,792
Mr. Pollack [Member]
Related Party Transactions (Details) [Line Items]
Shares of common stock (in Shares)				50,000,000
Salary			$ 66,000		$ 48,000		$ 11,000
Hunter Garth [Member]
Related Party Transactions (Details) [Line Items]
Salary	$ 8,000
Mr. Garth [Member]
Related Party Transactions (Details) [Line Items]
Shares of common stock (in Shares)	15,000,000
Exercise price (in Dollars per share)	$ 0.06
Common stock percentage		120.00%
Mr. Garth [Member] | 2021 Equity Incentive Plan [Member]
Related Party Transactions (Details) [Line Items]
Restricted common stock shares (in Shares)	22,500,000
Vested term	1 year
Michael Feinsod [Member]
Related Party Transactions (Details) [Line Items]
Salary	$ 10,000
Mr. Feinsod [Member]
Related Party Transactions (Details) [Line Items]
Shares of common stock (in Shares)	30,000,000
Exercise price (in Dollars per share)	$ 0.06
Common stock percentage		120.00%
Mr. Feinsod [Member] | 2021 Equity Incentive Plan [Member]
Related Party Transactions (Details) [Line Items]
Shares of common stock (in Shares)	45,000,000
Vested term	1 year
Chief Executive Officer [Member]
Related Party Transactions (Details) [Line Items]
Related party term						1 year
Related party renew terms						1 year
Shares of loaned (in Shares)							62,500
Repaid amount							$ 60,000
Note payable							$ 534
Series C Preferred Stock [Member]
Related Party Transactions (Details) [Line Items]
Common stock shares issued (in Shares)				1
Percentage of voting power				51.00%

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Dec. 14, 2021	Aug. 02, 2021	Apr. 27, 2021	Aug. 31, 2022	Sep. 30, 2020	Dec. 31, 2021
Commitments and Contingencies (Details) [Line Items]
Mr. Pollack an annual salary			$ 66,000
Mr. Pollack forgive salary						$ 11,000
Principal amount		$ 400,000
Executive officer salary	$ 8,000
Common stock ,options to purchase (in Shares)	30,000,000
Exercise price (in Dollars per share)	$ 0.06
Premium percentage	120.00%
Grant [Member]
Commitments and Contingencies (Details) [Line Items]
Common stock ,options to purchase (in Shares)	15,000,000
Securities Purchase Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Mr. Pollack an annual salary					$ 48,000
Equity Incentive Plan [Member]
Commitments and Contingencies (Details) [Line Items]
Restricted common stock (in Shares)	22,500,000
Common Stock [Member]
Commitments and Contingencies (Details) [Line Items]
Exercise price (in Dollars per share)	$ 0.06
Premium percentage	120.00%
Restricted common stock [Member]
Commitments and Contingencies (Details) [Line Items]
Restricted common stock (in Shares)	45,000,000
Chief Executive Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Executive officer salary	$ 10,000
Forecast [Member]
Commitments and Contingencies (Details) [Line Items]
Operating profit, percentage				40.00%
Final payment of inventory earn out				$ 75,000

Major Customers (Details)

Major Customers (Details)	4 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Total accounts receivable in percentage	10.00%
Total sales in percentage	10.00%	10.00%

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Feb. 08, 2022	Mar. 21, 2022	Jan. 19, 2022	Jan. 18, 2022
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Capital contribution				$ 4,792
Subsequent event, description				the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of 15,850,000 shares of common stock and warrants to purchase an aggregate of 3,962,500 shares of common stock, for an aggregate purchase price of $79,250. The warrants have a term of one year and an exercise price of $0.05.
Promissory note	$ 10,000		$ 10,000
Percentage of interest	5.00%		5.00%
Maturity date	Feb. 8, 2023		Jan. 18, 2023
Forecast [Member]
Subsequent Events (Details) [Line Items]
Subsequent event, description		the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of 3,000,000 shares of common stock and warrants to purchase an aggregate of 750,000 shares of common stock, for an aggregate purchase price of $15,000. The warrants have a term of one year and an exercise price of $0.05.